See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2015_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 154,875,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,726,000 |
| 3 | remainder_Assets | 206,000 |
| 4 | LiabilitiesCurrent | 13,059,000 |
| 5 | LiabilitiesNoncurrent | 279,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,127,435 |
| 9 | ResearchAndDevelopmentExpense | 54,759,449 |
| 10 | remainder_Expenses | 29,864 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 468,352 |
| 13 | remainder_ComprehensiveNetIncome | -16,505 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 156,807,000 |
| 1 | Liabilities | 13,338,000 |
| 2 | Expenses | 71,916,748 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 143,469,000 |
| 5 | NetIncome | -71,448,396 |
| 6 | ComprehensiveNetIncome | -71,456,648 |
| 7 | BaseVar | 121,273,302 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.84 |
| 9 | EconomicCapitalRatio | 3.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
